Can Epstein-Barr virus antibodies be used to screen for nasopharyngeal carcinoma?

It is a DNA virus first discovered in Africa and belongs to four human herpes viruses. The virus is also the first virus closely related to the occurrence of malignant tumors. It is closely related to the occurrence of nasopharyngeal carcinoma, lymphoma and some gastrointestinal tumors, especially Epstein-Barr virus infection in nasopharyngeal carcinoma. Epstein-Barr virus antibodies can be used as an auxiliary diagnostic method for early patients to improve cure rate and quality of life and reduce mortality. Screening for nasopharyngeal carcinoma includes Epstein-Barr virus antibodies, and Epstein-Barr virus infection is a high-risk factor for nasopharyngeal carcinoma.

Will the nasal cavity become dry after radiotherapy for nasopharyngeal carcinoma?

After radiotherapy, nasopharyngeal cancer patients generally experience dry nose, nasal pain, bloody nasal discharge, dry mouth and throat, neck skin burns or neck fibrosis, and may also affect the function of the jaw joint. Nasopharyngeal cancer generally does not cause dry nose, but can cause a series of related symptoms such as nasal congestion, bloody nasal discharge, hearing loss, and double vision. Nasopharyngeal cancer is a malignant tumor that occurs in the nasopharyngeal mucosa.

What are the symptoms of nasopharyngeal carcinoma liver metastasis?

Symptoms of nasopharyngeal carcinoma liver metastasis In addition to the primary tumor symptoms such as blood, tinnitus, liver pain, jaundice and other liver metastasis symptoms, the metastasis is generally in the late stage, and it is recommended to control it through radiotherapy and chemotherapy. Nasopharyngeal carcinoma is a common malignant tumor disease. Liver metastasis has entered the middle and late stages, and sometimes headaches, visual impairment, and protrusion of the eyeballs. If nasopharyngeal carcinoma metastasizes to the liver.